O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+33.09%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.07B
AUM Growth
+$7.07B
(+20%)
Cap. Flow
-$90.9M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
31.27%
Holding
162
New
21
Increased
29
Reduced
28
Closed
28
Top Buys
| 1 |
BNR
Burning Rock Biotech
BNR
|
$128M |
| 2 |
Repare Therapeutics
RPTX
|
$106M |
| 3 |
Oric Pharmaceuticals
ORIC
|
$98.6M |
| 4 |
Biogen
BIIB
|
$63M |
| 5 |
Keros Therapeutics
KROS
|
$63M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$255M |
| 2 |
Gilead Sciences
GILD
|
$98.4M |
| 3 |
Pfizer
PFE
|
$98.3M |
| 4 |
HCA Healthcare
HCA
|
$63.8M |
| 5 |
Stryker
SYK
|
$61.8M |
Sector Composition
| 1 | Healthcare | 97.61% |
| 2 | Financials | 1.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sutro Biopharma
STRO
$72.7M
| – | – | -104,800 | Closed | -$1.07M |
|
|
152
Stryker
SYK
$150B
| – | – | -371,100 | Closed | -$61.8M |
|
153
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | -127,200 | Closed | -$9.85M |
|
154
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | -113,200 | Closed | -$10M |
|
155
Zai Lab
ZLAB
$3.68B
| – | – | -254,000 | Closed | -$13.1M |
|
|
TVRD
156
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| – | – | -592,800 | Closed | -$7.83M |
|
|
NBSE
157
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| – | – | -371,114 | Closed | -$2.64M |
|
|
APTX
158
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – | -1,162,108 | Closed | -$2.51M |
|
|
AGRX
159
DELISTED
Agile Therapeutics, Inc
AGRX
| – | – | -1,200,000 | Closed | -$2.23M |
|
|
OTIC
160
DELISTED
Otonomy, Inc.
OTIC
| – | – | -71,994 | Closed | -$142K |
|
|
XENT
161
DELISTED
Intersect ENT, Inc
XENT
| – | – | -68,553 | Closed | -$812K |
|
|
PFNX
162
DELISTED
Pfenex Inc.
PFNX
| – | – | -1,305,034 | Closed | -$11.5M |
|